Skip to main content
TipRanks
Go Ultimate75% OFF

AnaptysBio (ANAB) Revenue

694 Followers

AnaptysBio Revenue

AnaptysBio had a revenue of 27.49M in the quarter ending Jun 30, 2026, with 7.56%. This bring the company's revenue in the last twelve months to 237.61M, Increased 2.25%. In the fiscal year ending Dec 31, 2025, AnaptysBio had annual revenue of 234.60M with 157.01% growth.

Revenue (ttm)
237.61M
Revenue Growth
92.92%
P/S Ratio
6.17
Revenue/Employee
$2,255,798
Employees
104
Market Cap
$1.45B

Revenue Chart

AnaptysBio Revenue - Annual

050M100M150M200M250M10.00M5.00M8.00M75.00M63.17M10.29M17.16M91.28M234.60M201720182019202020212022202320242025
Revenue History
Download to Excel
ANAB revenue history
Fiscal End DateRevenueChangeGrowth
Dec 31, 2025234.60M143.32M157.01%
Dec 31, 202491.28M74.12M432.03%
Dec 31, 202317.16M6.87M66.78%
Dec 31, 202210.29M-52.89M-83.72%
Dec 31, 202163.17M-11.82M-15.77%
Dec 31, 202075.00M67.00M837.50%
Dec 31, 20198.00M3.00M60.00%
Dec 31, 20185.00M-5.00M-50.00%
Dec 31, 201710.00M――
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Related stocks
CompanyRevenue
ANAB237.61M
XNCR200.49M
CTMX14.03M
CRVS0.00
ZYME265.97M
CGEM0.00